PK, Tolerability and Safety of the co-Administration of Sancuso® (Transdermal Granisetron) and IV Granisetron
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This study has been designed to investigate the pharmacokinetic and safety profile of the
co-administration of intravenous (IV) and transdermal granisetron, as well as characterise
the pharmacokinetics of multiple transdermal dosing.